Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Prostate Cancer”

2,712 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,712 results

Large-scale testing (Phase 3)Study completedNCT00117286
What this trial is testing

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 57
Not applicableLooking for participantsNCT06473259
What this trial is testing

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Santa Chiara Hospital 3,000
Testing effectiveness (Phase 2)Ended earlyNCT00670046
What this trial is testing

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Not applicableStudy completedNCT00242060
What this trial is testing

Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy

Who this might be right for
Elevated PSAProstate Cancer
University Health Network, Toronto
Not applicableUnknownNCT04835454
What this trial is testing

Role of Piwi-protein Interacting RNA, miRNA-194 and Amino Acids in Patients With Prostate Cancer

Who this might be right for
Finding New Biomarkers That Could be Evaluated in Patients With Prostate Cancer and Clarify Their Role in Early Detection of Prostate Cancer
Assiut University 120
Testing effectiveness (Phase 2)Looking for participantsNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00151073
What this trial is testing

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Who this might be right for
Hormone-Refractory Prostate Cancer
University of Michigan Rogel Cancer Center 28
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Very early researchStudy completedNCT03661437
What this trial is testing

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

Who this might be right for
Prostate Carcinoma
City of Hope Medical Center 33
Early research (Phase 1)Ended earlyNCT00565227
What this trial is testing

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Who this might be right for
Non-Small-Cell Lung CarcinomaProstate CancerBladder Cancer+1 more
University of Michigan Rogel Cancer Center 12
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)Study completedNCT00964002
What this trial is testing

Efavirenz in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Bergonié 61
Testing effectiveness (Phase 2)Study completedNCT00085228
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 116
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Testing effectiveness (Phase 2)Study completedNCT03007732
What this trial is testing

Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

Who this might be right for
Prostatic Neoplasms
David Oh 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT05232578
What this trial is testing

Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness

Who this might be right for
Prostate Cancer
General University Hospital, Prague 380
Testing effectiveness (Phase 2)Looking for participantsNCT05726292
What this trial is testing

Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Chicago 90
Large-scale testing (Phase 3)Study completedNCT00002511
What this trial is testing

Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,005
Not applicableStudy completedNCT02128334
What this trial is testing

An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation

Who this might be right for
Advanced Prostate Carcinoma
Astellas Pharma Europe B.V. 645
Large-scale testing (Phase 3)Study completedNCT03103321
What this trial is testing

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

Who this might be right for
Stage II Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer+5 more
Alliance for Clinical Trials in Oncology 158
Load More Results